Epistasis between hyperglycemic QTLs revealed in a double congenic of the OLETF rat.
Glucose homeostasis is believed to be regulated by multiple genetic components, in addition to numerous external factors. It is therefore crucial to dissect and understand what roles each causative gene plays in maintaining proper glucose metabolism. In OLETF (Otsuka Long-Evans Tokushima Fatty) rat, a model of polygenic type 2 diabetes, at least 14 quantitative trait loci (QTLs) influencing plasma glucose levels were identified. In congenic strains some of the OLETF allelic variants were shown to increase glucose levels. In this study the focus was on two of the hyperglycemic loci, Nidd1/of and Nidd2/of. Congenic rats possessing OLETF genome fragment at either locus showed similar levels of mild hyperglycemia. A newly established double congenic rat showed a further aggravation of hyperglycemia. The Nidd1/of locus was also shown to function in the reduction of plasma leptin levels and fat weights, while the Nidd2/of locus led to increased plasma insulin and fat weights. Interestingly, both plasma leptin and fat weights reverted to the control levels in the double congenic rat. These results indicate that there is an epistatic interaction between the two loci. However, it is unlikely that the abnormal level of enhanced glucose homeostasis is mediated, at least not directly, by leptin or fat mass.
Kose
Hiroyuki
H
Division for Animal Research Resources, Institute of Health Biosciences, The University of Tokushima Graduate School, Kuramoto-cho, Tokushima, 770-8503, Japan.
Bando
Yoshimi
Y
Izumi
Keisuke
K
Yamada
Takahisa
T
Matsumoto
Kozo
K
D000818:Animals; D030801:Animals, Genetically Modified; D001786:Blood Glucose / Q000235:genetics; D002874:Chromosome Mapping; D003921:Diabetes Mellitus, Experimental / Q000150:complications / Q000235:genetics / Q000473:pathology; D004843:Epistasis, Genetic; D005260:Female; D006943:Hyperglycemia / Q000209:etiology / Q000235:genetics*; D007515:Islets of Langerhans / Q000473:pathology; D008297:Male; D010195:Pancreatitis / Q000209:etiology / Q000473:pathology; D010641:Phenotype; D040641:Quantitative Trait Loci; D051381:Rats; D011916:Rats, Inbred F344; D020334:Rats, Inbred OLETF
D001786:Blood Glucose
Nat Genet. 1996 Dec;14(4):371-3
8944011
Mamm Genome. 2002 Oct;13(10):558-62
12420133
Mol Cell. 1998 Nov;2(5):559-69
9844629
Nature. 1994 Nov 10;372(6502):186-90
7526222
Mamm Genome. 1999 Mar;10(3):249-58
10051320
Diabetes Care. 1998 Apr;21(4):518-24
9571335
Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6231-5
8692797
Nature. 2002 Jul 25;418(6896):426-30
12110844
Nature. 1995 Sep 14;377(6545):151-5
7675081
Cell. 2001 Feb 23;104(4):517-29
11239409
Endocrinology. 1995 May;136(5):2143-9
7720663
Hum Mol Genet. 2002 Oct 1;11(20):2463-8
12351582
Metabolism. 1996 Apr;45(4):475-80
8609834
Hum Mol Genet. 2003 Feb 15;12(4):435-9
12566390
J Clin Invest. 1998 Apr 15;101(8):1591-5
9541488
Diabetes Nutr Metab. 2002 Apr;15(2):68-83
12059095
J Clin Invest. 2003 Dec;112(12):1821-30
14679177
Diabetes. 2005 Mar;54(3):909-14
15734873
Diabetologia. 2001 Apr;44(4):501-6
11357482
Nat Med. 2001 Oct;7(10):1138-43
11590438
Nature. 2001 Dec 13;414(6865):782-7
11742409
Cell Metab. 2006 Oct;4(4):291-302
17011502
Diabetes Res Clin Pract. 1995 Feb;27(2):97-106
7607057
Proc Natl Acad Sci U S A. 1994 May 24;91(11):4854-8
8197147
Nature. 1994 Nov 10;372(6502):182-6
7969452
Genome Res. 2000 Oct;10(10):1568-78
11042154
PLoS Biol. 2005 May;3(5):e135
15799711
J Med Invest. 2005 Feb;52(1-2):109-13
15751281
Diabetes. 2000 Jan;49(1):32-8
10615947
Genomics. 2000 Nov 15;70(1):19-25
11087657
Hum Hered. 2003;56(1-3):73-82
14614241
J Mol Med (Berl). 2003 Aug;81(8):455-70
12879149
Am J Hum Genet. 2001 Sep;69(3):553-69
11484155
Proc Assoc Am Physicians. 1998 Nov-Dec;110(6):545-58
9824537
Nature. 1997 Sep 25;389(6649):374-7
9311777
Biochem J. 2001 May 15;356(Pt 1):257-67
11336659
J Biol Chem. 2003 Nov 14;278(46):45638-50
12925533